Literature DB >> 18214435

Mannose-binding lectin and pulmonary morbidity in premature infants.

Rachel S Agbeko, Mark J Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18214435     DOI： 10.1007/s00134-008-1004-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Mannose-binding lectin and its genetic variants.

Authors:  P Garred; F Larsen; J Seyfarth; R Fujita; H O Madsen
Journal:  Genes Immun       Date:  2006-03       Impact factor: 2.676

2.  Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis.

Authors:  M Matsushita; H Miyakawa; A Tanaka; M Hijikata; K Kikuchi; H Fujikawa; J Arai; S Sainokami; K Hino; I Terai; S Mishiro; M E Gershwin
Journal:  J Autoimmun       Date:  2001-11       Impact factor: 7.094

3.  Mannose-binding lectin polymorphisms and pulmonary outcome in premature neonates: a pilot study.

Authors:  Ettore Capoluongo; Giovanni Vento; Sandro Rocchetti; Emiliano Giardina; Paola Concolino; Cecilia Sinibaldi; Concetta Santonocito; Valentina Vendettuoli; Milena Tana; Chiara Tirone; Cecilia Zuppi; Costantino Romagnoli; Giuseppe Novelli; Bruno Giardina; Franco Ameglio
Journal:  Intensive Care Med       Date:  2007-07-26       Impact factor: 17.440

4.  Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin.

Authors:  Katy J Fidler; Peter Wilson; Jane C Davies; Malcolm W Turner; Mark J Peters; Nigel J Klein
Journal:  Intensive Care Med       Date:  2004-05-04       Impact factor: 17.440

Review 5.  Mannose-binding lectin in innate immunity: past, present and future.

Authors:  R M Dommett; N Klein; M W Turner
Journal:  Tissue Antigens       Date:  2006-09
  5 in total
  1 in total

Review 1.  Genetics of bronchopulmonary dysplasia in the age of genomics.

Authors:  Pascal M Lavoie; Marie-Pierre Dubé
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.